DE3586773D1 - Verfahren zur beseitigung von n-endaminosaeureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide. - Google Patents

Verfahren zur beseitigung von n-endaminosaeureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide.

Info

Publication number
DE3586773D1
DE3586773D1 DE8585904198T DE3586773T DE3586773D1 DE 3586773 D1 DE3586773 D1 DE 3586773D1 DE 8585904198 T DE8585904198 T DE 8585904198T DE 3586773 T DE3586773 T DE 3586773T DE 3586773 D1 DE3586773 D1 DE 3586773D1
Authority
DE
Germany
Prior art keywords
polypeptide
eukaryotpolypeptide
endaminoaid
plants
remains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585904198T
Other languages
English (en)
Other versions
DE3586773T2 (de
Inventor
Shmaryahu Blumberg
Meir Daniela Ben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAVIENT PHARMACEUTICALS, INC. (N.D.GES.D. STAATES
Original Assignee
Savient Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Savient Pharmaceuticals Inc filed Critical Savient Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3586773D1 publication Critical patent/DE3586773D1/de
Publication of DE3586773T2 publication Critical patent/DE3586773T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DE8585904198T 1984-08-16 1985-08-09 Verfahren zur beseitigung von n-endaminosaeureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide. Expired - Lifetime DE3586773T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64148884A 1984-08-16 1984-08-16
PCT/US1985/001531 WO1986001229A1 (en) 1984-08-16 1985-08-09 Method of removing n-terminal amino acid residues from eucaryotic polypetide analogs and polypeptides produced thereby

Publications (2)

Publication Number Publication Date
DE3586773D1 true DE3586773D1 (de) 1992-11-26
DE3586773T2 DE3586773T2 (de) 1993-03-18

Family

ID=24572607

Family Applications (4)

Application Number Title Priority Date Filing Date
DE8585904198T Expired - Lifetime DE3586773T2 (de) 1984-08-16 1985-08-09 Verfahren zur beseitigung von n-endaminosaeureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide.
DE3588249T Expired - Lifetime DE3588249T2 (de) 1984-08-16 1985-08-09 Methode zur Herstellung von menschlichen Wachstumshormonen
DE19853588249 Active DE122004000009I2 (de) 1984-08-16 1985-08-09 Methode zur Herstellung von menschlichen Wachstumshormonen
DE200412000009 Pending DE122004000009I1 (de) 1984-08-16 1985-08-09 Methode zur Herstellung von menschlichen Wachstumshormonen.

Family Applications After (3)

Application Number Title Priority Date Filing Date
DE3588249T Expired - Lifetime DE3588249T2 (de) 1984-08-16 1985-08-09 Methode zur Herstellung von menschlichen Wachstumshormonen
DE19853588249 Active DE122004000009I2 (de) 1984-08-16 1985-08-09 Methode zur Herstellung von menschlichen Wachstumshormonen
DE200412000009 Pending DE122004000009I1 (de) 1984-08-16 1985-08-09 Methode zur Herstellung von menschlichen Wachstumshormonen.

Country Status (11)

Country Link
EP (2) EP0191827B1 (de)
JP (1) JPH0822240B2 (de)
AT (2) ATE251217T1 (de)
AU (1) AU591464B2 (de)
CA (1) CA1318869C (de)
DE (4) DE3586773T2 (de)
HK (1) HK143096A (de)
IL (1) IL76107A (de)
LU (1) LU91064I2 (de)
WO (1) WO1986001229A1 (de)
ZA (1) ZA856194B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK55685A (da) * 1985-02-07 1986-08-08 Nordisk Gentofte Enzym eller enzymkompleks med proteolytisk aktivitet
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
IL76360A0 (en) * 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
US4861868A (en) * 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes
WO1986007380A1 (en) * 1985-06-04 1986-12-18 Takeda Chemical Industries, Ltd. Process for preparing polypeptide
US4865974A (en) * 1985-09-20 1989-09-12 Cetus Corporation Bacterial methionine N-terminal peptidase
US5013662A (en) * 1985-09-20 1991-05-07 Cetus Corporation Bacterial methionine n-terminal peptidase
GB2188322A (en) * 1986-03-26 1987-09-30 Bayer Ag Aprotinin and analogues thereof produced by a recombinant host
GB8703015D0 (en) * 1987-02-10 1987-03-18 Biogen Nv Aminopeptidase
US5032573A (en) * 1987-03-23 1991-07-16 Bayer Aktiengesellschaft Homologs of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
DE3811921A1 (de) * 1988-04-09 1989-10-19 Hoechst Ag Verfahren zur herstellung von proteinen, die n-terminal mit prolin beginnen
US5079345A (en) * 1988-08-19 1992-01-07 Eli Lilly And Company Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
DE69231467T2 (de) * 1991-05-10 2001-01-25 Genentech Inc Auswählen von agonisten und antagonisten von liganden
US6429186B1 (en) 1991-05-10 2002-08-06 Genentech, Inc. Ligand antagonists for treatment of breast cancer
GB9225021D0 (en) * 1992-11-30 1993-01-20 Sandoz Ltd Organic compounds
KR970010135B1 (ko) * 1993-06-17 1997-06-21 주식회사 엘지화학 신규 아미노펩티다제
AU2445495A (en) * 1994-05-09 1995-11-29 Unizyme Laboratories A/S An enzymatic process for producing a desired protein from an amino terminal extended protein
KR100369839B1 (ko) * 1997-02-28 2003-06-12 주식회사 엘지생명과학 바실러스리케니포미스균주에서유래한아미노펩티다제,그의제조방법및이를이용한천연형단백질의제조방법
CN1322211A (zh) * 1998-10-05 2001-11-14 武田药品工业株式会社 除去n－末端蛋氨酸的方法
US6743600B1 (en) 1999-04-30 2004-06-01 Monsanto Technologies Llc Method of removing N-terminal alanine residues from polypeptides with Aeromonas aminopeptidase
US6794159B1 (en) 1999-04-30 2004-09-21 Pharmacia Corporation Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase
CA2460309C (en) * 2001-09-13 2012-07-10 Genentech, Inc. Aminopeptidase
US7820409B2 (en) 2004-06-23 2010-10-26 Usv, Ltd. Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
EP2206777B1 (de) 2007-10-29 2014-01-15 JCR Pharmaceuticals CO., LTD. Verfahren zur herstellung von aminopeptidase
KR20090124204A (ko) * 2008-05-29 2009-12-03 (주)바이오큐어팜 아미노 말단의 메티오닌이 제거된 재조합 사람 변이인터페론-베타 단백질을 생산하는 재조합 대장균 및 이의제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60184A (en) * 1979-05-31 1984-05-31 Schering Ag Process for the specific cleavage of protein sequences from proteins
JPS60500043A (ja) * 1982-12-10 1985-01-17 ノルデイスク・インスリンラボラトリウム 原核細胞又は真核細胞中で合成される融合蛋白質から成熟蛋白質を作る方法
DK55685A (da) * 1985-02-07 1986-08-08 Nordisk Gentofte Enzym eller enzymkompleks med proteolytisk aktivitet
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
WO1986007380A1 (en) * 1985-06-04 1986-12-18 Takeda Chemical Industries, Ltd. Process for preparing polypeptide

Also Published As

Publication number Publication date
IL76107A (en) 1991-03-10
JPH0822240B2 (ja) 1996-03-06
EP0191827B1 (de) 1992-10-21
DE3586773T2 (de) 1993-03-18
ATE81673T1 (de) 1992-11-15
EP0489711B1 (de) 2003-10-01
IL76107A0 (en) 1985-12-31
EP0489711A3 (en) 1992-10-07
DE3588249D1 (de) 2003-11-06
DE3588249T2 (de) 2004-05-06
LU91064I2 (en) 2004-05-26
AU4773985A (en) 1986-03-07
CA1318869C (en) 1993-06-08
DE122004000009I2 (de) 2006-09-07
HK143096A (en) 1996-08-09
AU591464B2 (en) 1989-12-07
DE122004000009I1 (de) 2004-11-18
ATE251217T1 (de) 2003-10-15
ZA856194B (en) 1986-04-30
EP0191827A4 (de) 1988-09-28
WO1986001229A1 (en) 1986-02-27
JPS62500003A (ja) 1987-01-08
EP0191827A1 (de) 1986-08-27
EP0489711A2 (de) 1992-06-10

Similar Documents

Publication Publication Date Title
DE3586773D1 (de) Verfahren zur beseitigung von n-endaminosaeureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide.
ATE372383T1 (de) Verfahren zur herstellung von l-aminosäuren
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
ATE68830T1 (de) Verfahren zur erhoehung der ausbeute von heterologen proteinen, produziert durch zuechtung von rekombinanten bakterien.
DE69210645D1 (de) Verfahren zur Herstellung von cysteinfreien Peptiden
ATE90944T1 (de) Fuer ein hirudinaehnliches protein kodierende dns- sequenz und verfahren zur herstellung eines solchen proteins.
FI880017A0 (fi) Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu
PT92603A (pt) Processo de producao de factor de crescimento transformante, quimerico,beta
ATE71110T1 (de) Verfahren zur reinigung eines proteins.
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
ATE113986T1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
KR940009329A (ko) 딕티오스텔륨 디펩티딜아미노펩티다아제
DE69028935D1 (de) Methode zur Produktion von Glukagon
ATE122099T1 (de) Verfahren zur herstellung von c-terminalen alpha- amidierten peptiden.
DE60040771D1 (de) Verfahren zur kontrolle der spaltung mit ompt protease
ATE140366T1 (de) Verfahren zur herstellung von eines pflanzliches eiweisshydrolysat
DE68904578D1 (de) Enzym zur alpha-amidierung von c-termini und verfahren zu dessen herstellung.
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
DE69827486D1 (de) Aminopeptidase, welche von bacillus licheniformis abstammt und verfahren zur herstellung von proteinen des natürlichen typs
ATE101616T1 (de) Verfahren zur herstellung von dipeptiden.
ATE139538T1 (de) Verfahren zur selektiven spaltung von fusionsproteinen
DK210288A (da) Overproduktion af exocelllulaere proteiner
KR850700041A (ko) 티-세포 증식인자

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SAVIENT PHARMACEUTICALS, INC. (N.D.GES.D. STAATES